-transparent.png){kind=logo}
Carminomycins II and III, the main components of the carminomycin complex were isolated in pure state. Their crystalline exalates and acetate of cardminomycin II were prepared. The PMR spectra of both carminomycins and the 13C-NMR spectra of the oxalates were obtained. The molecular weights of the antibiotics were determined by mass-spectrometry. On the basis of the PMR spectra it was shown that carminomycins II and III had similar structures and differed in the stereoisomerism of the nitrogen-free fragment linked to the amino sugar. This was confirmed by the 13C-NMR spectra. The above fragment (C7H15O3) is analogous to the fragment of baumycins A1 and A2 described earlier.
V B Zbarskiĭ, and
N P Potapova, and
M G Brazhnikova, and
B V Rozynov, and
L A Sibel'dina
August 1980,
Antibiotiki,
V B Zbarskiĭ, and
N P Potapova, and
M G Brazhnikova, and
B V Rozynov, and
L A Sibel'dina
April 1982,
Antibiotiki,
V B Zbarskiĭ, and
N P Potapova, and
M G Brazhnikova, and
B V Rozynov, and
L A Sibel'dina
January 1984,
The Journal of antibiotics,
V B Zbarskiĭ, and
N P Potapova, and
M G Brazhnikova, and
B V Rozynov, and
L A Sibel'dina
August 1996,
Inorganic chemistry,
V B Zbarskiĭ, and
N P Potapova, and
M G Brazhnikova, and
B V Rozynov, and
L A Sibel'dina
July 2013,
Dalton transactions (Cambridge, England : 2003),
V B Zbarskiĭ, and
N P Potapova, and
M G Brazhnikova, and
B V Rozynov, and
L A Sibel'dina
November 1959,
The Biochemical journal,
V B Zbarskiĭ, and
N P Potapova, and
M G Brazhnikova, and
B V Rozynov, and
L A Sibel'dina
January 2012,
Morfologiia (Saint Petersburg, Russia),
V B Zbarskiĭ, and
N P Potapova, and
M G Brazhnikova, and
B V Rozynov, and
L A Sibel'dina
February 2009,
Dalton transactions (Cambridge, England : 2003),
V B Zbarskiĭ, and
N P Potapova, and
M G Brazhnikova, and
B V Rozynov, and
L A Sibel'dina
January 2021,
Russian journal of general chemistry,
V B Zbarskiĭ, and
N P Potapova, and
M G Brazhnikova, and
B V Rozynov, and
L A Sibel'dina
September 1989,
The Journal of pharmacology and experimental therapeutics,
